3rd Quarter - Report

ROPES & GRAY, LLP for MEDICAL INFORMATION WORKING GROUP

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Enforcement priorities and policies regarding communications by pharmaceutical and medical device manufacturers about their medical products.

Foreign entity interest: Allergan, Plc, a pharmaceutical company identified on the Information Update page on the quarterly activity report (LD-2) for the second quarter of 2018, is a member of the Medical Information Working Group (MIWG), which seeks clarity in the FDA regulatory scheme regarding the dissemination of truthful non-misleading information about prescription drugs, biological products and medical devices, and to improve the federal regulatory framework and enforcement climate affecting manufacturer dissemination of information regarding those products.

LobbyistCovered position, as disclosed
KELLIE COMBS —
JOAN MCPHEE New —

Contacted: Justice, Dept of (DOJ)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.